Seeing Is Believing
CGEM is currently covered by 3 analysts with an average price target of $40.41. This is a potential upside of $15.11 (59.72%) from yesterday's end of day stock price of $25.3.
Cullinan Oncology LLC's activity chart (see below) currently has 8 price targets and 19 ratings on display. The stock rating distribution of CGEM is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 41.92% with an average time for these price targets to be met of 82.33 days.
Highest price target for CGEM is $34, Lowest price target is $34, average price target is $40.41.
Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 14-Aug-2023. First documented stock forecast 01-Feb-2021.
Currently out of the existing stock ratings of CGEM, 11 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
34
$15.11 (79.99%)
49
8 months 14 days ago
1/11 (9.09%)
$23.73 (231.06%)
28
Buy
19
$0.11 (0.58%)
40
1 years 2 months 25 days ago
2/3 (66.67%)
$7.23 (61.43%)
191
Buy
25
$6.11 (32.35%)
1 years 11 months 15 days ago
1/2 (50%)
$14.38 (135.40%)
28
What is CGEM (Cullinan Oncology LLC) average time for price targets to be met?
Which analyst has the current highest performing score on CGEM (Cullinan Oncology LLC) with a proven track record?
Which analyst has the current lower performing score on CGEM (Cullinan Oncology LLC) with a proven track record?
Which analyst has the most public recommendations on CGEM (Cullinan Oncology LLC)?
Which analyst is the currently most bullish on CGEM (Cullinan Oncology LLC)?
Which analyst is the currently most reserved on CGEM (Cullinan Oncology LLC)?